Results 11 to 20 of about 190,239 (217)

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines

npj Vaccines, 2022
SARS-CoV-2 neutralizing antibodies have been suggested to reflect the efficacy of COVID-19 vaccines. This study reports the direct comparison of the SARS-CoV-2 neutralizing antibody response elicited by a protein- (NVX-CoV2373), an mRNA- (Comirnaty), and
Michael Karbiener, Maria R. Farcet, Andreas Zollner, Taisei Masuda, Mitsuhiro Mori, Alexander R. Moschen, Thomas R. Kreil   +6 more
doaj   +1 more source

Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review [PDF]

Osong Public Health and Research Perspectives
This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 ...
Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, Hyoung-Shik Shin, Jun Hee Woo, Byung-Joo Park, Sanghoon Oh   +6 more
doaj   +1 more source

COVID-19 vaccine safety

Revista Peruana de Medicina Experimental y Salud Pública, 2021
The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic.
Nataniel Aldo Chaparro Mérida, Dayany Moreno Samper, Alex Omar Franco Lacato   +2 more
doaj   +1 more source

Safety of Vaccination within First Year of Life—The Experience of One General Medicine Center

Children, 2023
Vaccines represent an important preventive strategy in paediatric populations, but the rate of vaccination has been constantly declining in the last decade.
Claudia Felicia Pop, Petronela Coblisan, Ligia Capalna, Paraschiva Cherecheș Panța, Anca Dana Buzoianu, Ioana Corina Bocsan   +5 more
doaj   +1 more source

Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline

Frontiers in Public Health, 2022
Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Victoria's vaccine safety service for reporting adverse events following immunisation (AEFI), has provided integrated spontaneous surveillance and clinical services for ...
Ingrid Laemmle-Ruff, Georgina Lewis, Hazel J. Clothier, Hazel J. Clothier, Hazel J. Clothier, Gerardo Luis Dimaguila, Gerardo Luis Dimaguila, Michelle Wolthuizen, Jim Buttery, Jim Buttery, Jim Buttery, Jim Buttery, Nigel W. Crawford, Nigel W. Crawford, Nigel W. Crawford   +14 more
doaj   +1 more source

A social media intervention for communicating vaccine safety in low- and middle-income countries: protocol for a pilot study

Frontiers in Public Health, 2023
Vaccine safety is a concern that continues to drive hesitancy and refusal in populations in low-and-middle income countries (LMICs). Communicating about vaccine safety is a strategy that can successfully change personal and community perceptions and ...
Lucie Marisa Bucci, Smaragda Lamprianou, Francesco Gesualdo, Alberto E. Tozzi, Tala Ghalayini, Isabelle Sahinovic, Shanthi Pal   +6 more
doaj   +1 more source

Challenges and Innovations in Pharmacovigilance and Signal Management During the COVID-19 Pandemic: An Industry Perspective

Vaccines
Vaccine marketing authorization holders (MAHs) are responsible for the conduction of global vaccine pharmacovigilance on their vaccine products. A safety signal is detected when a new adverse event (AE) or aspect of an AE occurs after exposure to the ...
Maria Maddalena Lino, Susan Mather, Marianna Trani, Yan Chen, Patrick Caubel, Barbara De Bernardi   +5 more
doaj   +1 more source

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III)

Vaccines, 2023
The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic peptide ...
Alexander B. Ryzhikov, Evgeny A. Ryzhikov, Marina P. Bogryantseva, Svetlana V. Usova, Elena A. Nechaeva, Elena D. Danilenko, Stepan A. Pyankov, Andrey S. Gudymo, Anastasiya A. Moiseeva, Galina S. Onkhonova, Oleg V. Pyankov, Ekaterina S. Sleptsova, Nikita V. Lomakin, Veronika S. Vasilyeva, Mikhail V. Tulikov, Vitaly G. Gusarov, Andrey A. Pulin, Maria A. Balalaeva, Svetlana B. Erofeeva, Stanislav A. Terpigorev, Olga A. Rychkova, Ivan M. Petrov, Viktoriia Y. Delian, Vladimir V. Rafalskiy, Sergey V. Tyranovets, Elena V. Gavrilova, Rinat A. Maksyutov   +26 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

Molecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim, Maryam Aslam, Elouise Torruella, Alphons Sony, Asif Rahman, Simira Smith, Columba de la Parra, Moira Sauane   +7 more
wiley   +1 more source